Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World

Clinical trial NCT06874751 · COMPLETED

Trial details

NCT number: NCT06874751
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Overweight Obesity Atherosclerotic Cardiovascular Disease (ASCVD)

Start date: 2024-12-06
Primary completion: 2025-03-28
Enrollment: 45456

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.